Daniel Wilson MD

Daniel Wilson MD is an accomplished medical professional with extensive experience in hypertension and nephrology. After completing an internal medicine residency and a fellowship at the Cleveland Clinic, Daniel Wilson held various prominent roles, including Senior Medical Director at Bayer Pharmaceuticals and Executive Medical Director at Relypsa, where responsibilities included new product development for patiromer. Prior positions include a medical lead role at Pfizer and Senior Vice President of Clinical Development at KBP BioSciences. Daniel Wilson's educational background includes a Bachelor's degree in Biology from Franciscan University of Steubenville and a Doctor of Medicine from Rush Medical College. Daniel Wilson has been self-employed as a consultant in hypertension, nephrology, clinical development, and medical affairs.